Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models

Brain development during childhood and adolescence: a longitudinal MRI study

Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552 · see citing works

The adolescent brain and age-related behavioral manifestations

Spear, L. P. (2000) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00014-2 · Cited by 5,433 · see citing works

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092 · see citing works

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works

Untitled work

(2006) · PubMed · Cited by 3,378 · see citing works

A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data

Ennaceur, A., & Delacour, J. (1988) · Behavioural Brain Research · doi:10.1016/0166-4328(88)90157-x · Cited by 3,223 · see citing works

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · see citing works

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · see citing works

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224 · see citing works

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · see citing works

Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders

Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788 · see citing works

Adolescent Brain Development: A Period of Vulnerabilities and Opportunities. Keynote Address

DAHL, R. E. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1308.001 · Cited by 1,667 · see citing works

Role of Endogenous Cannabinoids in Synaptic Signaling

Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,567 · see citing works

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484 · see citing works

Identification and Functional Characterization of Brainstem Cannabinoid CB₂Receptors

Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470 · see citing works

Youth Risk Behavior Surveillance — United States, 2001

Grunbaum, J. A., Kann, L. K., Kinchen, S. A., Williams, B., Ross, J. G., Lowry, R., & Kolbe, L. J. (2002) · Journal of School Health · doi:10.1111/j.1746-1561.2002.tb07917.x · Cited by 1,412 · see citing works

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction

Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409 · see citing works

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.

Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399 · see citing works

Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the Enzyme

Lotta, T. I., Vidgren, J., Tilgmann, C., Ulmanen, I., Melén, K., Julkunen, I., & Taskinen, J. (1995) · Biochemistry · doi:10.1021/bi00013a008 · Cited by 1,167 · see citing works

Cannabis and schizophrenia. A longitudinal study of Swedish conscripts

Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92620-1 · Cited by 1,166 · see citing works

Schizophrenia as a Disorder of Neurodevelopment

Lewis, D. A., & Levitt, P. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142754 · Cited by 1,163 · see citing works

Adverse health effects of non-medical cannabis use

Hall, W., & Degenhardt, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61037-0 · Cited by 1,134 · see citing works

The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis

D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024 · see citing works

Stress, sensitive periods and maturational events in adolescent depression

Andersen, S. L., & Teicher, M. H. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.01.004 · Cited by 1,005 · see citing works

Cannabis use and psychosis: A longitudinal population-based study

van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928 · see citing works

Causal association between cannabis and psychosis: examination of the evidence

Arseneault, L., Cannon, M. D., Witton, J., & Murray, R. M. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.2.110 · Cited by 909 · see citing works

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study

Zammit, S., Allebeck, P., Andreasson, S., Lundberg, I., & Lewis, G. (2002) · BMJ · doi:10.1136/bmj.325.7374.1199 · Cited by 871 · see citing works

Cannabinoid CB2 receptors: immunohistochemical localization in rat brain

Gong, J.-P., Onaivi, E. S., Ishiguro, H., Liu, Q.-R., Tagliaferro, P. A., Brusco, A., & Uhl, G. R. (2006) · Brain Research · doi:10.1016/j.brainres.2005.11.035 · Cited by 820 · see citing works

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

Henquet, C., Krabbendam, L., Spauwen, J., Kaplan, C., Lieb, R., Wittchen, H.-U., & van Os, J. (2005) · BMJ · doi:10.1136/bmj.38267.664086.63 · Cited by 765 · see citing works

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680 · see citing works

Nonpsychotropic Cannabinoid Receptors Regulate Microglial Cell Migration

Walter, L. M., Franklin, A. A., Witting, A., Wade, C. B., Xie, Y., Kunos, G., Mackie, K., & Stella, N. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01398.2003 · Cited by 666 · see citing works

Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies

Macleod, J., Oakes, R., Copello, A., Crome, I., Egger, M., Hickman, M., Oppenkowski, T., Stokes-Lampard, H., & Smith, G. D. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16200-4 · Cited by 639 · see citing works

Cannabinoid Receptors: Where They are and What They do

Mackie, K. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01671.x · Cited by 638 · see citing works

High-potency cannabis and the risk of psychosis

Di Forti, M., Morgan, C., Dazzan, P., Pariante, C., Mondelli, V., Marques, T. R., Handley, R., Luzi, S., Russo, M., Paparelli, A., et al. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.064220 · Cited by 567 · see citing works

Hardwiring the Brain: Endocannabinoids Shape Neuronal Connectivity

Berghuis, P., Rajnicek, A. M., Morozov, Y. M., Ross, R. A., Mulder, J., Urbán, G. M., Monory, K., Marsicano, G., Matteoli, M., Canty, A. J., et al. (2007) · Science · doi:10.1126/science.1137406 · Cited by 551 · see citing works

Early-onset cannabis use and cognitive deficits: what is the nature of the association?

Pope, H. G., Gruber, A. J., Hudson, J. I., Cohane, G. H., Huestis, M. A., & Yurgelun-Todd, D. A. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00334-4 · Cited by 541 · see citing works

Enzymatic pathways that regulate endocannabinoid signaling in the nervous system

Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008) · Chemical Reviews · doi:10.1021/cr0782067 · Cited by 529 · see citing works

Untitled work

(2008) · PubMed · Cited by 510 · see citing works

Regional Brain Abnormalities Associated With Long-term Heavy Cannabis Use

Yücel, M., Solowij, N., Respondek, C., Whittle, S., Fornito, A., Pantelis, C., & Lubman, D. I. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.6.694 · Cited by 495 · see citing works

Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

Giuffrida, A., Leweke, F. M., Gerth, C. W., Schreiber, D., Koethe, D., Faulhaber, J., Klosterkötter, J., & Piomelli, D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300558 · Cited by 481 · see citing works

The emerging functions of endocannabinoid signaling during CNS development

Harkany, T., Guzmán, M., Galve‐Roperh, I., Berghuis, P., Devi, L. A., & Mackie, K. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.12.004 · Cited by 432 · see citing works

Elevated endogenous cannabinoids in schizophrenia

Leweke, F. M., Giuffrida, A., Wurster, U., Emrich, H. M., & Piomelli, D. (1999) · Neuroreport · doi:10.1097/00001756-199906030-00008 · Cited by 431 · see citing works

Chronic Pubertal, but not Adult Chronic Cannabinoid Treatment Impairs Sensorimotor Gating, Recognition Memory, and the Performance in a Progressive Ratio Task in Adult Rats

Schneider, M., & Koch, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300225 · Cited by 425 · see citing works

Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug

Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Moreira, F. A., & Guimarães, F. S. (2006) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2006000400001 · Cited by 402 · see citing works

A Total Synthesis of dl-Δ1-Tetrahydrocannabinol, the Active Constituent of Hashish1

Mechoulam, R., & Gaoni, Y. (1965) · Journal of the American Chemical Society · doi:10.1021/ja01092a065 · Cited by 401 · see citing works

Endocannabinoid signaling system and brain reward: emphasis on dopamine

GARDNER, E. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.032 · Cited by 387 · see citing works

Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles.

Palmatier, M., Kang, M. A., & Kidd, K. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00098-0 · Cited by 385 · see citing works

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use

Dean, B., Sundram, S., Bradbury, R., Scarr, E., & Copolov, D. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00552-2 · Cited by 381 · see citing works

Schizophrenia-Relevant Behavioral Testing in Rodent Models: A Uniquely Human Disorder?

Powell, C. M., & Miyakawa, T. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.008 · Cited by 368 · see citing works

The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies

Laruelle, M. A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00054-5 · Cited by 357 · see citing works

Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the “Two hit hypothesis.”

Bayer, T. A., Falkai, P., & Maier, W. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00039-4 · Cited by 346 · see citing works

CB2receptors in the brain: role in central immune function

Cabral, G. A., Raborn, E. S., Griffin, L., Dennis, J., & Marciano‐Cabral, F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707584 · Cited by 346 · see citing works

Chronic Δ9-Tetrahydrocannabinol During Adolescence Provokes Sex-Dependent Changes in the Emotional Profile in Adult Rats: Behavioral and Biochemical Correlates

Rubino, T., Vigano', D., Realini, N., Guidali, C., Braida, D., Capurro, V., Castiglioni, C., Cherubino, F., Romualdi, P., Candeletti, S., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301664 · Cited by 345 · see citing works

Early adolescent cannabis exposure and positive and negative dimensions of psychosis

Stefanis, N. C., Delespaul, P., Henquet, C., Bakoula, C., Stefanis, C., & van Os, J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00806.x · Cited by 341 · see citing works

Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning

Mulder, J., Aguado, T., Keimpema, E., Barabás, K., Rosado, C. J. B., Nguyen, L., Monory, K., Marsicano, G., Marzo, V. D., Hurd, Y. L., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803545105 · Cited by 328 · see citing works

Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis

Morgan, C. J. A., & Curran, H. V. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046649 · Cited by 300 · see citing works

An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of Δ-9-Tetrahydrocannabinol-Induced Effects on Psychosis and Cognition

Henquet, C., Rosa, A., A, L. K. M., Papiol, S., Fañanás, L., Drukker, M., Ramaekers, J. G., & van Os, J. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301197 · Cited by 299 · see citing works

Presence of cannabinoid binding sites in the brain from early postnatal ages

de Fonseca, F. R., Ramos, J. A., Bonnin, A., & Fernández‐Ruíz, J. (1993) · Neuroreport · doi:10.1097/00001756-199302000-00005 · Cited by 297 · see citing works

Adolescent Rats Find Repeated Δ9-THC Less Aversive Than Adult Rats but Display Greater Residual Cognitive Deficits and Changes in Hippocampal Protein Expression Following Exposure

Quinn, H. R., Matsumoto, I., Callaghan, P. D., Long, L. E., Arnold, J. C., Gunasekaran, N., Thompson, M. R., Dawson, B., Mallet, P. E., Kashem, M. A., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301475 · Cited by 293 · see citing works

Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats

O’Shea, M., Singh, M. E., McGregor, I. S., & Mallet, P. E. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047277 · Cited by 292 · see citing works

Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor

Berghuis, P., Dobszay, M. B., Wang, X., Spano, S., Ledda, F., Sousa, K. M., Schulte, G., Ernfors, P., Mackie, K., Paratcha, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509494102 · Cited by 291 · see citing works

CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms

Beltramo, M., Bernardini, N., Bertorelli, R., Campanella, M., Nicolussi, E., Fredduzzi, S., & Reggiani, A. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04684.x · Cited by 290 · see citing works

Brain Morphological Changes and Early Marijuana Use

Wilson, W., Mathew, R., Turkington, T. G., Hawk, T. C., Coleman, R. E., & Provenzale, J. (2000) · Journal of Addictive Diseases · doi:10.1300/j069v19n01_01 · Cited by 288 · see citing works

First-Episode Psychosis: Psychopathology, Quality of Life, and Functional Outcome

MALLA, A. K. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi031 · Cited by 284 · see citing works

Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood

Rubino, T., Realini, N., Braida, D., Guidi, S., Capurro, V., Viganò, D., Guidali, C., Pinter, M., Sala, M., Bartesaghi, R., et al. (2009) · Hippocampus · doi:10.1002/hipo.20554 · Cited by 282 · see citing works

Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry

Lisdahl, K. M., Schweinsburg, A. D., Cohen‐Zion, M., Nagel, B. J., & Tapert, S. F. (2006) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2006.10.010 · Cited by 280 · see citing works

The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia

Moore, H. M., West, A. R., & Grace, A. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00078-5 · Cited by 274 · see citing works

Effects of cannabis use on outcomes of psychotic disorders: systematic review

Zammit, S., Moore, T. H., Lingford-Hughes, A. R., Barnes, T. R. E., Jones, P. B., Burke, M., & Lewis, G. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046375 · Cited by 272 · see citing works

Testing hypotheses about the relationship between cannabis use and psychosis

Degenhardt, L. J., Hall, W., & Lynskey, M. T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00064-4 · Cited by 270 · see citing works

Tests of causal linkages between cannabis use and psychotic symptoms

Fergusson, D. M., Horwood, L. J., & Ridder, E. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01001.x · Cited by 268 · see citing works

The effects of an early stressful life event on sensorimotor gating in adult rats

Ellenbroek, B. A., van den Kroonenberg, P. T. J. M., & Cools, A. R. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(97)00149-7 · Cited by 265 · see citing works

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia

Zavitsanou, K., Garrick, T. M., & Huang, X. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.11.005 · Cited by 264 · see citing works

The Cognitive Neuroscience of Memory Function and Dysfunction in Schizophrenia

Ranganath, C., Minzenberg, M., & Ragland, J. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.011 · Cited by 262 · see citing works

Altered brain tissue composition in heavy marijuana users

Matochik, J. A., Eldreth, D. A., Cadet, J.-L., & Bolla, K. I. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.06.011 · Cited by 260 · see citing works

Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol

Hillard, C. J. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00051-4 · Cited by 255 · see citing works

Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons

Wotherspoon, G., Fox, A., McIntyre, P., Colley, S., Bevan, S., & Winter, J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.009 · Cited by 251 · see citing works

Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation

Gruber, S. A., & Yurgelun-Todd, D. A. (2005) · Cognitive Brain Research · doi:10.1016/j.cogbrainres.2005.02.016 · Cited by 242 · see citing works

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use

Leweke, F. M., Giuffrida, A., Koethe, D., Schreiber, D., Nolden, B. M., Kranaster, L., Neatby, M. A., Schneider, M., Gerth, C. W., Hellmich, M., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.025 · Cited by 240 · see citing works

Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies

Lewis, D. A., & Sweet, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37335 · Cited by 235 · see citing works

Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain

Mato, S., del Olmo, E., & Pazos, Á. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02599.x · Cited by 232 · see citing works

Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats

O’Shea, M., McGregor, I. S., & Mallet, P. E. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106065188 · Cited by 230 · see citing works

Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects

Ellgren, M., Artmann, A., Tkalych, O., Gupta, A., Hansen, H. S., Hansen, S. H., Devi, L. A., & Hurd, Y. L. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.009 · Cited by 228 · see citing works

Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid system

Emrich, H. M., Leweke, F. M., & Schneider, U. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00426-1 · Cited by 226 · see citing works

Δ9-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study

Pistis, M., Ferraro, L., Pira, L., Flore, G., Tanganelli, S., Gessa, G. L., & Devoto, P. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03055-x · Cited by 226 · see citing works

Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia

Eggan, S. M., Hashimoto, T., & Lewis, D. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.7.772 · Cited by 219 · see citing works

A community survey of adverse effects of cannabis use

Thomas, H. (1996) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(96)01277-x · Cited by 217 · see citing works

Gestational methylazoxymethanol acetate administration: A developmental disruption model of schizophrenia

Lodge, D. J., & Grace, A. A. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.01.031 · Cited by 215 · see citing works

Cannabis and psychiatric disorders: it is not only addiction

Leweke, F. M., & Koethe, D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00106.x · Cited by 213 · see citing works

Cannabis, Vulnerability, and the Onset of Schizophrenia: An Epidemiological Perspective

Hambrecht, M., & Häfner, H. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2000.00736.x · Cited by 206 · see citing works

Psychotic Reactions Following Cannabis Use in East Indians

Chopra, G. S. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760070014002 · Cited by 195 · see citing works

Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study

Verdoux, H., Gindre, C., Sorbara, F., Tournier, M., & Swendsen, J. D. (2003) · Psychological Medicine · doi:10.1017/s0033291702006384 · Cited by 194 · see citing works

Endocannabinoid functions controlling neuronal specification during brain development

Harkany, T., Keimpema, E., Barabás, K., & Mulder, J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.02.011 · Cited by 187 · see citing works

Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression

Koethe, D., Llenos, I. C., Dulay, J. R., Hoyer, C., Torrey, Ε. F., Leweke, F. M., & Weis, S. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0660-5 · Cited by 187 · see citing works

A Clinical and Metabolic Study of Acute Intoxication with Cannabis Sativa and its Role in the Model Psychoses

Ames, F. R. (1958) · Journal of Mental Science · doi:10.1192/bjp.104.437.972 · Cited by 185 · see citing works

Brain Cannabinoid CB2 Receptor in Schizophrenia

Ishiguro, H., Horiuchi, Y., Ishikawa, M., Koga, M., Imai, K., Suzuki, Y., Morikawa, M., Inada, T., Watanabe, Y., Takahashi, M., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.024 · Cited by 184 · see citing works

Effects of frequent marijuana use on brain tissue volume and composition

Block, R. I., OʼLeary, D. S., Ehrhardt, J. C., Augustinack, J. C., Ghoneim, M. M., Arndt, S. V., & Hall, J. A. (2000) · Neuroreport · doi:10.1097/00001756-200002280-00013 · Cited by 182 · see citing works

Altered white matter microstructure in adolescent substance users

Bava, S., Frank, L. R., McQueeny, T. M., Schweinsburg, B. C., Schweinsburg, A. D., & Tapert, S. F. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2009.04.005 · Cited by 182 · see citing works

Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia

Newell, K. A., Deng, C., & Huang, X. (2006) · Experimental Brain Research · doi:10.1007/s00221-006-0503-x · Cited by 179 · see citing works

Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics

Arnone, D., Barrick, T. R., Chengappa, S., Mackay, C. E., Clark, C. A., & Abou-Saleh, M. T. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.02.064 · Cited by 178 · see citing works

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis

Koethe, D., Giuffrida, A., Schreiber, D., Hellmich, M., Schultze‐Lutter, F., Ruhrmann, S., Klosterkötter, J., Piomelli, D., & Leweke, F. M. (2009) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.108.053843 · Cited by 178 · see citing works

Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use

Zammit, S., Spurlock, G., Williams, H. J., Norton, N., Williams, N. M., O’Donovan, M. C., & Owen, M. J. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.036129 · Cited by 174 · see citing works

Cannabidiol Reverses MK-801-Induced Disruption of Prepulse Inhibition in Mice

Long, L. E., Malone, D. T., & TAYLOR, D. A. H. B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300838 · Cited by 173 · see citing works

Actions of cannabinoid receptor ligands on rat cultured sensory neurones: implications for antinociception

Ross, R. A., Coutts, A. A., McFarlane, S. M., Anavi-Goffer, S., Irving, A. J., Pertwee, R. G., MacEwan, D. J., & Scott, R. H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00135-0 · Cited by 172 · see citing works

Cannabinoids and prefrontal cortical function: Insights from preclinical studies

Egerton, A., Allison, C., Brett, R. R., & Pratt, J. A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.12.002 · Cited by 171 · see citing works

Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development

Berrendero, F., Garcı́a-Gil, L., Hernández, M., Romero, J., Cebeira, M., de Miguel, R., Ramos, J. A., & Fernández‐Ruíz, J. (1998) · Development · doi:10.1242/dev.125.16.3179 · Cited by 171 · see citing works

Hippocampal abnormalities and memory deficits: New evidence of a strong pathophysiological link in schizophrenia

Boyer, P., Phillips, J. L., Rousseau, F. L., & Ilivitsky, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.12.008 · Cited by 168 · see citing works

Endogenous Cannabinoids: Structure and Metabolism

Bisogno, T. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01676.x · Cited by 165 · see citing works

IMAGING STUDY: Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects

Lisdahl, K. M., McQueeny, T. M., Nagel, B. J., Hanson, K. L., Yang, T. T., & Tapert, S. F. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00166.x · Cited by 157 · see citing works

How antipsychotics become anti-‘psychotic’ – from dopamine to salience to psychosis

Kapur, S. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.06.005 · Cited by 156 · see citing works

The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats

Belue, R. C., Howlett, A. C., Westlake, T. M., & Hutchings, D. E. (1995) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(94)00053-g · Cited by 154 · see citing works

Preferential limbic expression of the cannabinoid receptor mRNA in the human fetal brain

Wang, X., Dow-Edwards, D. L., Keller, É., & Hurd, Y. L. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00020-4 · Cited by 154 · see citing works

A population based elaboration of the role of age of onset on the course of schizophrenia

Rabinowitz, J., Levine, S. Z., & Häfner, H. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.007 · Cited by 153 · see citing works

Progressive attenuation of the firing activity of locus coeruleus noradrenergic neurons by sustained administration of selective serotonin reuptake inhibitors

Szabo, S. T., de Montigny, C., & Blier, P. (2000) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145700001772 · Cited by 153 · see citing works

Role of cannabis and endocannabinoids in the genesis of schizophrenia

Fernández‐Espejo, E., Viveros, M., Núñez, L., Ellenbroek, B. A., & de Fonseca, F. R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1612-6 · Cited by 151 · see citing works

Different Effects of Nabilone and Cannabidiol on Binocular Depth Inversion in Man

Leweke, F. M., Schneider, U., Radwan, M., Schmidt, E., & Emrich, H. M. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00201-x · Cited by 150 · see citing works

Early maternal deprivation induces gender‐dependent changes on the expression of hippocampal CB1 and CB2 cannabinoid receptors of neonatal rats

Suárez, J., Llorente, R., Romero‐Zerbo, S., Mateos, B., Bermúdez‐Silva, F. J., de Fonseca, F. R., & Viveros, M. (2008) · Hippocampus · doi:10.1002/hipo.20537 · Cited by 142 · see citing works

Autoradiographic Study of Pre- and Postnatal Distribution of Cannabinoid Receptors in Human Brain

Biegon, A. R., & Kerman, I. A. (2001) · NeuroImage · doi:10.1006/nimg.2001.0939 · Cited by 135 · see citing works

The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex

Rubino, T., Realini, N., Braida, D., Alberio, T., Capurro, V., Viganò, D., Guidali, C., Sala, M., Fasano, M., & Parolaro, D. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9031-3 · Cited by 131 · see citing works

Cognitive and psychomotor effects in males after smoking a combination of tobacco and cannabis containing up to 69 mg delta-9-tetrahydrocannabinol (THC)

Hunault, C. C., Mensinga, T. T., Böcker, K. B. E., Schipper, C. M. A., Kruidenier, M., Leenders, M. E. C., de Vries, I., & Meulenbelt, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1440-0 · Cited by 128 · see citing works

Ultrastructural Localization of Neuronal Brain CB2 Cannabinoid Receptors

Brusco, A., Tagliaferro, P. A., Saez, T. M. M., & Onaivi, E. S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1432.037 · Cited by 127 · see citing works

Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia

Müller‐Vahl, K., & Emrich, H. M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.7.1037 · Cited by 126 · see citing works

A preliminary DTI study showing no brain structural change associated with adolescent cannabis use.

DeLisi, L. E., Bertisch, H. C., Szulc, K. U., Majcher, M., Brown, K., Bappal, A., & Ardekani, B. A. (2006) · Harm Reduction Journal · doi:10.1186/1477-7517-3-17 · Cited by 123 · see citing works

Is the Party Over? Cannabis and Juvenile Psychiatric Disorder: The Past 10 Years

Rey, J. M., Martin, A., & Krabman, P. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000135623.12843.60 · Cited by 119 · see citing works

Wiring and firing neuronal networks: endocannabinoids take center stage

Harkany, T., Mackie, K., & Doherty, P. (2008) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.08.007 · Cited by 118 · see citing works

Cannabis use in children and adolescents with first episode psychosis: Influence on psychopathology and short-term outcome (CAFEPS study)

Baeza, I., Graell, M., Moreno, D. M., Castro‐Fornieles, J., Parellada, M., González-Pinto, A. M., Payá, B., Soutullo, C. A., de la Serna, E., & Arango, C. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.04.005 · Cited by 116 · see citing works

Schizotypy and psychosis-like experiences from recreational cannabis in a non-clinical sample

Barkus, E., & Lewis, S. W. (2008) · Psychological Medicine · doi:10.1017/s0033291707002619 · Cited by 116 · see citing works

Sex differences in the effects of Δ9-tetrahydrocannabinol on spatial learning in adolescent and adult rats

Cha, Y. M., Jones, K. H., Kuhn, C. M., Wilson, W. A., & Swartzwelder, S. H. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee7b7e · Cited by 108 · see citing works

Cannabis use and psychotic disorders: an update

Hall, W., Degenhardt, L. J., & Teesson, M. (2004) · Drug and Alcohol Review · doi:10.1080/09595230412331324554 · Cited by 104 · see citing works

Cannabis use and brain structural alterations in first episode schizophrenia — A region of interest, voxel based morphometric study

Bangalore, S. S., Prasad, K. M. R., Montrose, D. M., Goradia, D. D., Diwadkar, V. A., & Keshavan, M. S. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.029 · Cited by 100 · see citing works

Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia

Viganò, D., Guidali, C., Petrosino, S., Realini, N., Rubino, T., Marzo, V. D., & Parolaro, D. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009371 · Cited by 99 · see citing works

Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales

Hickman, M., Vickerman, P. T., Macleod, J., Kirkbride, J. B., & Jones, P. B. (2007) · Addiction · doi:10.1111/j.1360-0443.2006.01710.x · Cited by 97 · see citing works

Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness

Koethe, D., Gerth, C. W., Neatby, M. A., Haensel, A., Thies, M., Schneider, U., Emrich, H. M., Klosterkötter, J., Schultze-Lutter, F., & Leweke, F. M. (2006) · Schizophrenia Research · doi:10.1016/j.schres.2006.07.023 · Cited by 93 · see citing works

The Disruption of Prepulse Inhibition by Social Isolation in the Wistar Rat: How Robust Is the Effect?

Domeney, A. M., & Feldon, J. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00534-0 · Cited by 92 · see citing works

Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats

Malone, D. T., Jongejan, D., & TAYLOR, D. A. H. B. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.010 · Cited by 91 · see citing works

Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment

Wegener, N., & Koch, M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.11.081 · Cited by 90 · see citing works

Cannabis, Cannabinoids and Schizophrenia: Integration of the Evidence

Cohen, M. A., Solowij, N., & Carr, V. J. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670801961156 · Cited by 90 · see citing works

Association of cannabis use with prodromal symptoms of psychosis in adolescence

Miettunen, J., Törmänen, S., Murray, G. K., Jones, P. B., Mäki, P., Ebeling, H., Moilanen, I., Taanila, A., Heinimaa, M., Joukamaa, M., et al. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.045740 · Cited by 85 · see citing works

Gender‐dependent cellular and biochemical effects of maternal deprivation on the hippocampus of neonatal rats: A possible role for the endocannabinoid system

Llorente, R., Llorente‐Berzal, A., Petrosino, S., Marco, E. M., Guaza, C., Prada, C., López‐Gallardo, M., Marzo, V. D., & Viveros, M. (2008) · Developmental Neurobiology · doi:10.1002/dneu.20666 · Cited by 85 · see citing works

Symptoms of schizotypy precede cannabis use

Schiffman, J. E., Nakamura, B. J., Earleywine, M., & LaBrie, J. W. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2005.01.004 · Cited by 79 · see citing works

The effect of Δ9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats

Malone, D. T., & TAYLOR, D. A. H. B. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.07.009 · Cited by 77 · see citing works

Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum

Guimaraes, V. H. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.01.015 · Cited by 75 · see citing works

Reduced binocular depth inversion in regular cannabis users

Semple, D. M., Ramsden, F., & McIntosh, A. M. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00140-0 · Cited by 74 · see citing works

Corpus callosum damage in heavy marijuana use: Preliminary evidence front diffusion tensor tractography and tract-based spatial statistics

Abou‐Saleh, M. T., Arnone, D., Barrick, T. R., Chengappa, S., Clark, C., & Mackay, C. E. (2008) · The International Journal of Neuropsychopharmacology · Cited by 73 · see citing works

Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55,212-2

Schneider, M., Drews, E., & Koch, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200509000-00018 · Cited by 72 · see citing works

The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion

SCHNEIDER, M., & Koch, M. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.03.009 · Cited by 71 · see citing works

Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999

BOYDELL, J., VAN OS, J., CASPI, A., KENNEDY, N., GIOUROUKOU, E., FEARON, P., FARRELL, M., & MURRAY, R. M. (2006) · Psychological Medicine · doi:10.1017/s0033291706008440 · Cited by 70 · see citing works

Item Response Theory Analysis of DSM-IV Cannabis Abuse and Dependence Criteria in Adolescents

Hartman, C. A., Gelhorn, H. L., Crowley, T. J., Sakai, J. T., Stallings, M. C., Young, S. E., Rhee, S. H., Corley, R. P., Hewitt, J. K., & Hopfer, C. J. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815cd9f2 · Cited by 69 · see citing works

The association between early cannabis use and psychotic-like experiences in a community adolescent sample

Hides, L., Lubman, D. I., Buckby, J., Yuen, H. P., Cosgrave, E., Baker, K., & Yung, A. R. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.04.001 · Cited by 69 · see citing works

Prevalence and correlates of past-year substance use, abuse, and dependence in a suburban community sample of high-school students

Chen, K. M., Sheth, A. J., Elliott, D. K., et al. (2003) · Addictive Behaviors · doi:10.1016/j.addbeh.2003.08.013 · Cited by 68 · see citing works

Impact of substance use on the onset and course of early psychosis

Verdoux, H., Tournier, M., & Cougnard‐Grégoire, A. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2004.12.008 · Cited by 68 · see citing works

Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats

Malone, D. T., Kearn, C. S., Chongue, L., Mackie, K., & TAYLOR, D. A. H. B. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.043 · Cited by 65 · see citing works

Development of Cannabinoid 1 Receptor Protein and Messenger RNA in Monkey Dorsolateral Prefrontal Cortex

Eggan, S. M., Mizoguchi, Y., Stoyak, S. R., & Lewis, D. A. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp179 · Cited by 64 · see citing works

Role of the endogenous cannabinoid system as a modulator of dopamine transmission: Implications for Parkinson’s disease and schizophrenia

de Fonseca, F. R., Gorriti, M. Á., Bilbao, A., Escuredo, L., García‐Segura, L. M., Piomelli, D., & Navarro, M. (2001) · Neurotoxicity Research · doi:10.1007/bf03033228 · Cited by 63 · see citing works

Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment

Emrich, H. M., Weber, M. M., Wendl, A., Zihl, J., Meyer, L., & Hanisch, W. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90383-d · Cited by 62 · see citing works

Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia

SCHWARCZ, G., Karajgi, B. M., & McCarthy, R. H. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a6bc3b · Cited by 62 · see citing works

Cannabis use and age of diagnosis of schizophrenia

Sugranyes, G., Flamarique, I., Parellada, E., Baeza, I., Goti, J., Fernández-Egea, E., & Bernardo, M. (2009) · European Psychiatry · doi:10.1016/j.eurpsy.2009.01.002 · Cited by 59 · see citing works

Leptin receptor deficiency is associated with upregulation of cannabinoid 1 receptors in limbic brain regions

Thanos, P. K., Ramalhete, R. C., Michaelides, M., Piyis, Y. K., Wang, G., & Volkow, N. D. (2008) · Synapse · doi:10.1002/syn.20531 · Cited by 59 · see citing works

The hypothalamic levels of the endocannabinoid, anandamide, peak immediately before the onset of puberty in female rats

Wenger, T., Gerendai, I., Fezza, F., González, S. R., Bisogno, T., Fernández‐Ruíz, J., & Marzo, V. D. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01516-8 · Cited by 58 · see citing works

Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine

Guidali, C., Viganò, D., Petrosino, S., Zamberletti, E., Realini, N., Binelli, G., Rubino, T., Marzo, V. D., & Parolaro, D. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000209 · Cited by 56 · see citing works

Changing incidence of psychotic disorders among the young in Zurich

Ajdacic‐Gross, V., Lauber, C., Warnke, I., Haker, H., Murray, R. M., & Wulf Rössler, A. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.06.001 · Cited by 47 · see citing works

Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats

Rasmussen, B. A., O’Neil, J. N., Manaye, K. F., et al. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0584-z · Cited by 41 · see citing works

Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?

Peters, B. D., de Haan, L., Vlieger, E.-J., et al. (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4310 · Cited by 40 · see citing works

Adolescent Cannabis Use, Psychosis and Catechol-O-Methyltransferase Genotype in African Americans and Caucasians

Kantrowitz, J. T., Nolan, K. A., Sen, S., et al. (2009) · Psychiatric Quarterly · doi:10.1007/s11126-009-9108-4 · Cited by 38 · see citing works

Cannabis-Induced Psychosis

Spencer, D. J. (1971) · International Journal of the Addictions · doi:10.3109/10826087109057790 · Cited by 35 · see citing works

Relationship of Catechol-O-Methyltransferase to Schizophrenia and Its Correlates: Evidence for Associations and Complex Interactions

Lewandowski, K. E. (2007) · Harvard Review of Psychiatry · doi:10.1080/10673220701650409 · Cited by 29 · see citing works

Cannabis Induced Psychosis

SPENCER, D. J. (1970) · British Journal of Addiction to Alcohol & Other Drugs · doi:10.1111/j.1360-0443.1970.tb03956.x · Cited by 26 · see citing works

Marijuana: Use Among Young Males and Health Outcomes

Pujazon-Zazik, M., & Park, M. J. (2009) · American Journal of Men s Health · doi:10.1177/1557988309340577 · Cited by 14 · see citing works

Age-Related Changes in Frontal and Temporal Lobe Volumes in Men: A Magnetic Resonance Imaging Study

Bartzokis, G., Beckson, M., Lu, P. H., Nuechterlein, K. H., Edwards, N., & Mintz, J. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.461 · Cited by 14 · see citing works

Cannabidiol increases Fos expression in the nucleus accumbens but not in the dorsal striatum

Guimaraes, V. H. (2004) · Life Sciences · doi:10.1016/s0024-3205(04)00291-7 · Cited by 10 · see citing works

Cannabis and psychosis: two kinds of limitations which attach to epidemiological research

Fergusson, D. M. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00699.x · Cited by 6 · see citing works

Adolescence as a sensitive period of brain development

Fuhrmann, D., Knoll, L. J., & Blakemore, S.-J. (2015) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2015.07.008 · Cited by 1,158 · see citing works

The <scp>P</scp> harmacologic and <scp>C</scp> linical <scp>E</scp> ffects of <scp>M</scp> edical <scp>C</scp> annabis

Borgelt, L. M., Franson, K. L., Nussbaum, A. M., & Wang, G. S. (2013) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1187 · Cited by 423 · see citing works

Cannabis and adolescent brain development.

Lubman, D. I., Cheetham, A., & Yücel, M. (2015) · Pharmacology &amp; Therapeutics · doi:10.1016/j.pharmthera.2014.11.009 · Cited by 360 · see citing works

The persistence of the association between adolescent cannabis use and common mental disorders into young adulthood

Degenhardt, L., Coffey, C., Romaniuk, H., Swift, W., Carlin, J. B., Hall, W. D., & Patton, G. C. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04015.x · Cited by 237 · see citing works

Consequences of adolescent drug use

Steinfeld, M. R., & Torregrossa, M. M. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02590-4 · Cited by 237 · see citing works

The impact of state medical marijuana legislation on adolescent marijuana use.

Choo, E. K., Benz, M., Zaller, N., Warren, O., Rising, K. L., & McConnell, K. J. (2014) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2014.02.018 · Cited by 189 · see citing works

Does puberty mark a transition in sensitive periods for plasticity in the associative neocortex?

Piekarski, D. J., Johnson, C. M., Boivin, J. R., Thomas, A. W., Lin, W. C., Delevich, K., M. Galarce, E., & Wilbrecht, L. (2017) · Brain Research · doi:10.1016/j.brainres.2016.08.042 · Cited by 175 · see citing works

Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats

Zamberletti, E., Beggiato, S., Steardo, L., Prini, P., Antonelli, T., Ferraro, L., Rubino, T., & Parolaro, D. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.10.028 · Cited by 147 · see citing works

The long-term cognitive consequences of adolescent exposure to recreational drugs of abuse

Mooney-Leber, S. M., & Gould, T. J. (2018) · Learning &amp; Memory · doi:10.1101/lm.046672.117 · Cited by 140 · see citing works

Emerging adult age status predicts poor buprenorphine treatment retention

Schuman-Olivier, Z., Weiss, R. D., Hoeppner, B. B., Borodovsky, J., & Albanese, M. J. (2014) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2014.04.006 · Cited by 127 · see citing works

Cannabis use in adolescence and risk of psychosis: Are there factors that moderate this relationship? A systematic review and meta-analysis

Kiburi, S. K., Molebatsi, K., Ntlantsana, V., & Lynskey, M. T. (2021) · Substance Abuse · doi:10.1080/08897077.2021.1876200 · Cited by 115 · see citing works

Associations of cannabis and cigarette use with psychotic experiences at age 18: Findings from the Avon Longitudinal Study of Parents and Children

Gage, S. H., Hickman, M., Heron, J., Munafò, M. R., Lewis, G., Macleod, J., & Zammit, S. (2014) · Psychological Medicine · doi:10.1017/s0033291714000531 · Cited by 91 · see citing works

Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD‐11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys

Degenhardt, L., Bharat, C., Bruno, R., Glantz, M. D., Sampson, N. A., Lago, L., Aguilar‐Gaxiola, S., Alonso, J., Andrade, L. H., Bunting, B., et al. (2019) · Addiction · doi:10.1111/add.14482 · Cited by 60 · see citing works

Characteristics of clinically anxious versus non-anxious regular, heavy marijuana users

Van Dam, N. T., Bedi, G., & Earleywine, M. (2012) · Addictive Behaviors · doi:10.1016/j.addbeh.2012.05.021 · Cited by 26 · see citing works

Comparison between delta-9-tetrahydrocannabinol and cannabis extract on resorption rate in mice.

Abel, E. L., & Dintcheff, B. A. (1986) · PubMed

Effects of delta-9-tetrahydrocannabinol on social behaviour in the laboratory mouse and rat

Cutler, M. G., & Mackintosh, J. H. (1975) · Psychopharmacology · doi:10.1007/bf00428908 · Cited by 24 · see citing works

Rapid tolerance to Δ9-tetrahydrocannabinol and cross-tolerance between ethanol and Δ9-tetrahydrocannabinol in mice

Silva, G. E. D., Morato, G. S., & Takahashi, R. N. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01449-2 · Cited by 25 · see citing works

Influence of cannabis and delta-9-tetrahydrocannabinol on the biochemistry of the male reproductive organs

Chakravarty, I., & Ghosh, J. J. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90053-8 · Cited by 10 · see citing works

Modulation of acute effects of delta-9-tetrahydrocannabinol on psychotomimetic effects, cognition and brain function by previous cannabis exposure

Colizzi, M., McGuire, P. K., Giampietro, V., Williams, S., Brammer, M. J., & Bhattacharyya, S. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.04.003 · Cited by 28 · see citing works